Press Releases | 8 May 2017

bioLytical Partners With Pasante on UK Distribution of INSTI HIV Self Test

With over 1,000,000 INSTI tests already sold to practitioners in the UK, Pasante has grown INSTI to be a market leader in the point of care sector.

Read More »

News | 7 May 2017

Mixed reactions to HIV self-testing kit but doctors upbeat

Nearly 500,000 Kenyans are infected with HIV and should be on antiretroviral (ARV) treatment.
Kenyans above 15 years will be able to purchase, perform the HIV test and interpret the results on their own and at their convenience.

Read More »

News | 5 May 2017

Kenya launches self-test kits and PrEP

With the launch, Kenya becomes the first country to undertake a national roll-out of HIV self-testing and the second in Africa to bring to scale PrEP for prevention of HIV infection for those at high risk. Kenya is committed to revitalizing HIV prevention while ensuring access to treatment. – JACKSON KIOKO DIRECTOR OF MEDICAL SERVICES, MINISTRY OF HEALTH, KENYA

Read More »


  • bioLytical® Laboratories develops and manufactures a rapid HIV diagnostic product, the INSTI® Kit. It is a unique, simple-to-use diagnostic kit used in the diagnosis of HIV infection. At 60 seconds for a reading, INSTI® Kit is the fastest HIV diagnostic assay in the world today. The INSTI® HIV-1/HIV-2 Antibody Test is a rapid in vitro qualitative test for the detection of antibodies to Human Immunodeficiency Virus Type 1 or Type 2 in human whole blood, fingerstick blood, or plasma.

  • You are currently viewing content for the US region. Accept